CAMP LEJEUNE COMPENSATION LAWSUITS
Between the years of 1953-1987, the drinking water at the United States Marine Corps (USMC) Base Camp Lejeune in Jacksonville, North Carolina was found to be contaminated with toxic chemicals. The USMC discovered the toxins in 1982, claiming to have removed the sources of contamination by 1985.
How to get started on your Camp Lejeune compensation case now
The First Step To Get Compensated
Reach out to our attorneys that have a proven track record of fighting for justice against medical malpractice, nursing home abuse, serious injuries or wrongful deaths.
The Second Step To Get Compensated
Tell us your story about you or your loved one living or working at Camp Lejeune to determine your eligibility for compensation for your medical bills and suffering.
The Third Step To Get Compensated
If we determine you are eligible, we will tirelessly fight for compensation for medical bills and other expenses from your pain and suffering.
THE CAMP LEJEUNE ACT OF 2022
Thanks to The Camp Lejeune Act, passed by the Senate in 2022 it is now possible for veterans, their families, and contracted personnel, who lived near or were stationed in Camp Lejeune for more than 30 days between the years of 1953-1987, to file for compensation to pay for medical expenses and the pain and suffering they’ve endured as a result of toxic water.
If you or a loved were stationed at, worked in, or lived near Camp Lejeune, North Carolina, in between the years of 1953-1987 and suffered from the effects of the toxic water you may be eligible for compensation from a Camp Lejeune lawsuit.
Marines, their families, and contracted civilian workers who have been exposed to the water at Camp Lejeune, NC during 1953 to 1987, have an increased risk for several types of cancers, birth defects, miscarriages, and other serious illnesses including:
- Bladder cancer
- Breast cancer
- Esophageal cancer
- Female infertility
- Hepatic steatosis
- Kidney cancer
- Leukemia
- Lung cancer
- Miscarriage
- Multiple myeloma
- Birth defects
- Scleroderma
- Non-Hodgkin’s lymphoma
- Renal toxicity
- Neurobehavioral effects
- Myelodysplastic syndromes